Ana Drozdowskyj
Instituto Oncologico Dr Rosell
Barcelona, CT, Spain
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Personalized tumor-loaded monocyte-derived dendritic cell vaccination in combination with atezolizumab as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): phase Ib-II VENEZOLUNG trial.
Journal: Journal for immunotherapy of cancer
Published: July 08, 2026
Prognostic Significance of PD-L1 Expression on Circulating Myeloid-Derived Suppressor Cells in NSCLC Patients Treated with Anti-PD-1/PD-L1 Checkpoint Inhibitors.
Journal: International journal of molecular sciences
Published: October 11, 2024
Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: May 06, 2024
Access to melanoma drugs in Spain: a cross-sectional survey.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: March 29, 2024
SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: August 28, 2022
Multiplex Analysis of CircRNAs from Plasma Extracellular Vesicle-Enriched Samples for the Detection of Early-Stage Non-Small Cell Lung Cancer.
Journal: Pharmaceutics
Published: August 08, 2022
The EPICAL trial, a phase Ib study combining first line afatinib with anti-EGF vaccination in EGFR-mutant metastatic NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 15, 2021
Intermittent BRAF inhibition in advanced BRAF mutated melanoma results of a phase II randomized trial.
Journal: Nature communications
Published: March 26, 2021
COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study.
Journal: Journal of the American Academy of Dermatology
Published: September 19, 2020
BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib.
Journal: JTO clinical and research reports
Published: June 18, 2020
Combination of gefitinib and olaparib versus gefitinib alone in EGFR mutant non-small-cell lung cancer (NSCLC): A multicenter, randomized phase II study (GOAL).
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 25, 2020
Last Updated: 09/26/2026